Visual Function and Patient Satisfaction After Bilateral Implantation of AcrySof Natural ReSTOR (Model SN60D3) or AcrySof Natural Monofocal (Model SN60AT)
The purpose of the study is:
- to compare visual parameters (Subjective refraction and Visual Acuity (VA)) and safety (tilt, decentration and posterior chamber opacification (PCO)) in a prospective series of 40 patients after bilateral implantation of AcrySof Natural ReSTOR (Model SN60D3) or AcrySof Natural Monofocal (Model SN60AT)
- to assess patient satisfaction before and after implant
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76134
- Contact Alcon Call Center for Trial Locations
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion:
- Written informed consent
- Age: ≥ 50 years ≤ 75 years
- Bilateral age related cataract, to be extracted and followed by the implantation of Posterior Chamber Intraocular Lenses (IOLs)
- Pre-operative and post-operative astigmatism ≤ 1 Diopter (D), as from Keratometry readings
- Potential post operative Visual Acuity (VA) ≥ 20/40
- Second eye surgery to take place no longer than 45 days after the first implant
Exclusion:
- Irregular optical aberrations;
- Pupil diameter in scotopic conditions more than 6 mm
- Degenerative visual pathologies (ex: Age-related Macular Degeneration (AMD))
- Other exclusions as from ReSTOR Directions for Use (DFU)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: SN60D3
AcrySof Natural ReSTOR Intraocular Lens (IOL) Model SN60D3
|
Bilateral implantation with the AcrySof Natural ReSTOR Intraocular Lens (IOL) SN60D3 following cataract removal.
|
|
Active Comparator: SN60AT
AcrySof Natural Monofocal Intraocular Lens (IOL) Model SN60AT
|
Bilateral implantation with the AcrySof Natural Intraocular Lens (IOL) Model SN60AT following cataract removal.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Near Best Corrected Visual Acuity (BCVA) - Binocular
Time Frame: 6 months after second eye implantation
|
Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye).
This test was conducted binocularly and with best correction.
The effect of treatment was tested by Chi-square test.
VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain.
VA is measured in logMAR which is the "logarithm of the minimum angle of resolution".
A lower logMAR value indicates better VA.
|
6 months after second eye implantation
|
|
Near Uncorrected Visual Acuity (UCVA) Binocular
Time Frame: 6 months after second eye implantation
|
Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye).
This test was conducted binocularly and with no correction.
The effect of treatment was tested by Chi-square test.
VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain.
VA is measured in logMAR which is the "logarithm of the minimum angle of resolution".
A lower logMAR value indicates better VA.
|
6 months after second eye implantation
|
|
Near Best Corrected Visual Acuity Left Eye (BCVA LE)
Time Frame: 6 months after second eye implantation
|
Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye).
This test was conducted monocularly (left eye only) and with best correction.
The effect of treatment was tested by Chi-square test.
VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain.
VA is measured in logMAR which is the "logarithm of the minimum angle of resolution".
A lower logMAR value indicates better VA.
|
6 months after second eye implantation
|
|
Near Uncorrected Visual Acuity Left Eye (UCVA LE)
Time Frame: 6 months after second eye implantation
|
Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye).
This test was conducted monocularly (left eye only) and with no correction.
The effect of treatment was tested by Chi-square test.
VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain.
VA is measured in logMAR which is the "logarithm of the minimum angle of resolution".
A lower logMAR value indicates better VA.
|
6 months after second eye implantation
|
|
Near Best Corrected Visual Acuity Right Eye (BCVA RE)
Time Frame: 6 months after second eye implantation
|
Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye).
This test was conducted monocularly (right eye only) and with best correction.
The effect of treatment was tested by Chi-square test.
VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain.
VA is measured in logMAR which is the "logarithm of the minimum angle of resolution".
A lower logMAR value indicates better VA.
|
6 months after second eye implantation
|
|
Near Uncorrected Visual Acuity Right Eye (UCVA RE)
Time Frame: 6 months after second eye implantation
|
Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye).
This test was conducted monocularly (right eye only) and with no correction.
The effect of treatment was tested by Chi-square test.
VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain.
VA is measured in logMAR which is the "logarithm of the minimum angle of resolution".
A lower logMAR value indicates better VA.
|
6 months after second eye implantation
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IT 06 01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.